Cargando…

Long-term administration of escitalopram in patients with social anxiety disorder in Japan

PURPOSE: To investigate the safety, tolerability, and effectiveness of escitalopram in patients with social anxiety disorder in Japan. METHODS: A 52-week, open-label study was conducted in Japanese patients with social anxiety disorder with a total score ≥60 on the Liebowitz Social Anxiety Scale – J...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asakura, Satoshi, Hayano, Taiji, Hagino, Atsushi, Koyama, Tsukasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966576/ https://www.ncbi.nlm.nih.gov/pubmed/27524899 http://dx.doi.org/10.2147/NDT.S108983

Ejemplares similares

Post-Marketing Surveillance of Fluvoxamine Maleate Used Long-Term in Patients with Social Anxiety Disorder in Japan
por: Asakura, Satoshi, et al.
Publicado: (2014)

Resistant social anxiety disorder response to Escitalopram
por: Pallanti, Stefano, et al.
Publicado: (2006)

Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy
por: Hjorth, Olof, et al.
Publicado: (2022)

Early Improvement in One Week Predicts the Treatment Response to Escitalopram in Patients with Social Anxiety Disorder: A Preliminary Study
por: Oh, Kang-Seob, et al.
Publicado: (2016)

Long-Term Use of Escitalopram and a High Level of Carcinoembryonic Antigen
por: Ceylan, Mehmet Emin, et al.
Publicado: (2016)

Do You Believe It? Verbal Suggestions Influence the Clinical and Neural Effects of Escitalopram in Social Anxiety Disorder: A Randomized Trial
por: Faria, Vanda, et al.
Publicado: (2017)

Comparing the Therapeutic Effects of Crocin, Escitalopram and Co-Administration of Escitalopram and Crocin on Learning and Memory in Rats with Stress-Induced Depression
por: Joodaki, Mehran, et al.
Publicado: (2021)

Short-term escitalopram treatment and hippocampal volume
por: Godlewska, Beata R., et al.
Publicado: (2014)

Japanese Society of Anxiety and Related Disorders/Japanese Society of Neuropsychopharmacology: Clinical practice guideline for social anxiety disorder (2021)
por: Asakura, Satoshi, et al.
Publicado: (2023)

The therapeutic potential of escitalopram in the treatment of panic disorder
por: Townsend, Mark H, et al.
Publicado: (2007)

Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial
por: Strawn, Jeffrey R., et al.
Publicado: (2021)

Long-term Escitalopram Treatment in Korean Patients with Panic Disorder: A Prospective, Naturalistic, Open-label, Multicenter Trial
por: Choi, Kwan-Woo, et al.
Publicado: (2012)

Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation
por: Silva, Soraia, et al.
Publicado: (2021)

Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder
por: François, C, et al.
Publicado: (2008)

Antidepressants for social anxiety disorder: A systematic review and meta‐analysis
por: Mitsui, Nobuyuki, et al.
Publicado: (2022)

An emerging role for escitalopram in the treatment of obsessive-compulsive disorder
por: Hedges, Dawson W, et al.
Publicado: (2007)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Ali, Mazen K, et al.
Publicado: (2011)

Feasibility, and barriers to use escitalopram in functional gastrointestinal disorders
por: Alkhowaiter, Saad S., et al.
Publicado: (2023)

Escitalopram induced mania
por: Parker, Shubangi, et al.
Publicado: (2007)

Escitalopram in patients with psoriasis
por: Artemieva, M., et al.
Publicado: (2021)

Escitalopram Induced Angioedema
por: Conde, Samantha L, et al.
Publicado: (2022)

Association Between Social Isolation and Smoking in Japan and England
por: Ikeda, Takaaki, et al.
Publicado: (2021)

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
por: Aldrich, Stacey L., et al.
Publicado: (2019)

Predictors of social anxiety disorder with major depressive episodes among Japanese university students
por: Watanabe, Shinya, et al.
Publicado: (2021)

Long-term disability in anxiety disorders
por: Hendriks, Sanne M., et al.
Publicado: (2016)

Mild cognitive disorder and depression: treatment with combination of galantamine and escitalopram
por: Zarra, Julio, et al.
Publicado: (2010)

Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
por: Mencacci, Claudio, et al.
Publicado: (2013)

Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety
por: Wang, Gang, et al.
Publicado: (2018)

Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled Trial
por: Kang, Hee-Ju, et al.
Publicado: (2017)

Blunted autonomic reactivity to pharmacological panic challenge under long-term escitalopram treatment in healthy men
por: Agorastos, Agorastos, et al.
Publicado: (2015)

Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats
por: Favaro, Vanessa Manchim, et al.
Publicado: (2015)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Interaction between escitalopram and risperidone
por: Rao, Pradeep, et al.
Publicado: (2005)

Severe hyponatremia associated with escitalopram
por: Rawal, Gautam, et al.
Publicado: (2017)

Escitalopram-induced extrapyramidal symptoms
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2019)

Rise of escitalopram and the fall of citalopram
por: Cavanah, Luke R., et al.
Publicado: (2023)

Long-term oxytocin administration improves social behaviors in a girl with autistic disorder
por: Kosaka, Hirotaka, et al.
Publicado: (2012)

Hypnic jerks possibly induced by escitalopram
por: Sathe, Harshal, et al.
Publicado: (2015)

Mydriasis caused by ESCITALOPRAM: Case report
por: Bouattour, N., et al.
Publicado: (2022)

Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population
por: Jiang, Kaida, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vt1fop7rqh11e4mq0aef5dd0e8